Funds and ETFs biote Corp.

Equities

BTMD

US0906831039

Professional Information Services

Market Closed - Nasdaq 16:00:00 2024-05-10 EDT 5-day change 1st Jan Change
6.12 USD -2.08% Intraday chart for biote Corp. +1.83% +23.89%

ETFs positioned on biote Corp.

Name Weight AuM 1st Jan change Investor Rating
0.00% 0 M€ +3.63% -
biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
6.12 USD
Average target price
8.648 USD
Spread / Average Target
+41.31%
Consensus
  1. Stock Market
  2. Equities
  3. BTMD Stock
  4. Funds and ETFs biote Corp.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW